e-learning
resources
Virtual 2020
Pre-Congress Content
Clinical management of lung transplant recipients
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence and outcomes of diabetes in lung transplant recipients: the portuguese experience
M. de Sousa Moreira (Lisboa, Portugal), S. Silva (Lisboa, Portugal), A. Magalhães (Lisboa, Portugal), S. Alfarroba (Lisboa, Portugal), L. Semedo (Lisboa, Portugal), J. Cardoso (Lisboa, Portugal)
Source:
Virtual Congress 2020 – Clinical management of lung transplant recipients
Session:
Clinical management of lung transplant recipients
Session type:
E-poster session
Number:
1938
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. de Sousa Moreira (Lisboa, Portugal), S. Silva (Lisboa, Portugal), A. Magalhães (Lisboa, Portugal), S. Alfarroba (Lisboa, Portugal), L. Semedo (Lisboa, Portugal), J. Cardoso (Lisboa, Portugal). Prevalence and outcomes of diabetes in lung transplant recipients: the portuguese experience. 1938
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Open label case-control study to assess Pidotimod efficacy in Non CF Bronchiectasis Disease: a pilot study
Related content which might interest you:
Prevalence of SDB in lung transplant recipients
Source: Breathe 2010; 6: 274
Year: 2010
Impact of diabetes mellitus on survival and hospitalization after lung transplantation
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016
Chronic lung allograft disease: prevalence and FEV1 decline in a Brazilian lung transplant cohort.
Source: International Congress 2017 – Lung transplant outcomes
Year: 2017
Estimation of quality of life (QoL) of lung transplant recipients by members of the transplant team in comparison with the patients‘ perception
Source: Eur Respir J 2006; 28: Suppl. 50, 723s
Year: 2006
Tuberculosis infection in renal transplant recipients and evaluation of risk factors.>
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020
Improving lung transplant outcomes in France: the high emergency lung transplantation programme
Source: Eur Respir J, 59 (1) 2102209; 10.1183/13993003.02209-2021
Year: 2022
Prevalence and echocardiographic screening for pulmonary hypertension in liver transplantation recipients
Source: International Congress 2019 – Pulmonary hypertension: clinical
Year: 2019
Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016
Improvements in functional and cognitive status following short-term pulmonary rehabilitation in COPD lung transplant recipients: a pilot study
Source: ERJ Open Res, 5 (3) 00060-2019; 10.1183/23120541.00060-2019
Year: 2019
Poor patient adherence may contribute to increased skin cancer risk in heart and lung transplant recipients
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016
CMV management in lung transplant recipients
Source: School Course 2012 - Lung Transplantation
Year: 2012
Does smoking affect the prevalence of BOS after lung transplantation?
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008
Chronic respiratory complications in paediatric heart transplant recipients
Source: Eur Respir J 2006; 28: Suppl. 50, 311s
Year: 2006
Impact of drug knowledge on drug errors in an outpatient population of lung transplant recipients
Source: Eur Respir J 2007; 30: Suppl. 51, 176s
Year: 2007
Aspergillus
infections in lung transplant recipients. Risk factors and outcome
Source: Eur Respir J 2004; 24: Suppl. 48, 178s
Year: 2004
Specificities of the paediatric lung transplant recipient
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005
SARS-CoV-2 infection in transplant recipients: experience of a COVID-19 unit in Portugal
Source: Virtual Congress 2021 – COVID - 19 around the globe
Year: 2021
Outcomes of telehealth care for lung transplant recipients
Source: Virtual Congress 2021 – Lung graft allocation and monitoring in the 21st century
Year: 2021
The impact of diabetes mellitus on healthcare costs in Taiwanese patients with respiratory failure
Source: Annual Congress 2010 - Respiratory system involvement in non-pulmonary disorders
Year: 2010
Short and mid-term outcomes of lung transplant recipients with COVID-19
Source: Virtual Congress 2021 – Challenging problems in lung transplantation
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept